PT - JOURNAL ARTICLE AU - Araújo, Miguel B. AU - Naimi, Babak TI - Spread of SARS-CoV-2 Coronavirus likely to be constrained by climate AID - 10.1101/2020.03.12.20034728 DP - 2020 Jan 01 TA - medRxiv PG - 2020.03.12.20034728 4099 - http://medrxiv.org/content/early/2020/03/16/2020.03.12.20034728.short 4100 - http://medrxiv.org/content/early/2020/03/16/2020.03.12.20034728.full AB - As new cases of SARS CoV-2 (aka 2019-nCoV) Coronavirus are confirmed throughout the world and millions of people are being put into quarantine, few doubt the virus will reach pandemic state. Some worry it could badly hit the developing world, such as sub-Saharan Africa, potentially leading to a global human calamity. It is still early days, but using existing data we develop a large ensemble of ecological niche models that project monthly variation in climate suitability of SARS-CoV-2 Coronavirus throughout a typical climatological year. The current spread suggests a degree of climate determination with Coronavirus displaying preference for cool and dry conditions. The predecessor SARS-CoV was linked to similar climate conditions. Should the spread of SARS CoV-2 continue to follow current trends, a worst-case scenario of synchronous global pandemic is improbable. More probable is the emergence of asynchronous seasonal global outbreaks much like other respiratory diseases. People in temperate warm and cold climates are more vulnerable. Those in arid climates follow next in vulnerability, while the disease will likely marginally affect the tropics. Our projections minimize uncertainties related with spread of SARS CoV-2, providing critical information for anticipating the adequate social, economic and political responses.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNAAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is in public repositories.